Market revenue in 2023 | USD 203.0 million |
Market revenue in 2030 | USD 302.0 million |
Growth rate | 5.8% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Kits & Reagents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Lateral Flow Readers |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Roche, Bio-Rad Laboratories Inc, BioMerieux SA, QuidelOrtho Corp, Hologic Inc, PerkinElmer, Merck KGaA, BD, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lateral flow assays market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 68.08% in 2023. Horizon Databook has segmented the Mexico lateral flow assays market based on kits & reagents, lateral flow readers covering the revenue growth of each sub-segment from 2018 to 2030.
An increase in Strategic initiatives undertaken by major market players is anticipated to propel market growth during the forecast period. For instance, in August 2021, the National Institute of Genomic Medicine of Mexico Government and Sorrento Mexico signed a Memorandum of Understanding for accelerating the development of COVID-19 diagnostics and therapeutics.
In addition, various untapped opportunities in Mexico could make the process faster and feasible. For instance, most of the Mexican states already have government-funded screening programs.
Several other countries have already implemented HPV testing and these testing kits can be purchased at affordable prices due to a regional pooled procurement mechanism. HPV diagnosis has been approved for primary screening in Argentina, Columbia, and Mexico.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico lateral flow assays market , including forecasts for subscribers. This country databook contains high-level insights into Mexico lateral flow assays market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account